We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-14 of 14 results
  1. Toll-like receptor 5-mediated signaling enhances liver regeneration in mice

    Background

    Toll-like receptor 5 (TLR5)-mediated pathways play critical roles in regulating the hepatic immune response and show hepatoprotective...

    Wen Zhang, Lei Wang, ... **ao-Ming Yang in Military Medical Research
    Article Open access 23 February 2021
  2. Therapeutic applications of toll-like receptors (TLRs) agonists in AML

    Acute myeloid leukemia (AML) is an aggressive type of blood cancer affecting bone marrow (BM). In AML, hematopoietic precursors are arrested in the...

    Ye Peng, Yanzhong Wang, ... Yirui Chen in Clinical and Translational Oncology
    Article 13 August 2022
  3. TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming

    Immune checkpoint inhibitors have revolutionized anti-tumor therapy, notably improving treatment responses in various tumors. However, many patients...

    Junseok Lee, Keon-Il Im, ... Seok-Goo Cho in Cancer Immunology, Immunotherapy
    Article Open access 17 April 2024
  4. The gut microbiota as a booster for radiotherapy: novel insights into radio-protection and radiation injury

    Approximately 60–80% of cancer patients treated with abdominopelvic radiotherapy suffer post-radiotherapy toxicities including radiation enteropathy...

    Yuxi Yi, Weiqing Lu, ... Zhen Zhang in Experimental Hematology & Oncology
    Article Open access 22 May 2023
  5. Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments

    Treatment for cancer has the potential to significantly diminish fertility and, further, to negatively impact the obstetrical outcomes of pregnancies...

    D. Garg, E. B. Johnstone, ... J. M. Letourneau in Journal of Assisted Reproduction and Genetics
    Article 28 April 2020
  6. The pathogenesis of mucositis: updated perspectives and emerging targets

    Mucositis research and treatment are a rapidly evolving field providing constant new avenues of research and potential therapies. The MASCC/ISOO...

    J. Bowen, N. Al-Dasooqi, ... S. Elad in Supportive Care in Cancer
    Article 08 July 2019
  7. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy

    Toll-like receptor 5 (TLR5) is considered an attractive target for anticancer immunotherapy. TLR5 agonists, bacterial flagellin and engineered...

    V Mett, E A Komarova, ... A V Gudkov in Oncogene
    Article Open access 02 October 2017
  8. Harnessing innate immune pathways for therapeutic advancement in cancer

    The innate immune pathway is receiving increasing attention in cancer therapy. This pathway is ubiquitous across various cell types, not only in...

    Ankang Hu, Li Sun, ... Ying Mao in Signal Transduction and Targeted Therapy
    Article Open access 25 March 2024
  9. Targeting Toll-Like Receptors for Cancer Therapy

    The immune system encompasses a broad array of defense mechanisms against foreign threats, including invading pathogens and transformed neoplastic...

    Marc J. Braunstein, John Kucharczyk, Sylvia Adams in Targeted Oncology
    Article 18 September 2018
  10. Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure

    Background

    Preclinical studies on irradiated animals show that thrombocytopenia can play a role in radiation mortality, particularly in animals...

    Andrea L. DiCarlo, Joseph M. Kaminski, ... Bert W. Maidment in Journal of Radiation Oncology
    Article 01 July 2015
  11. Radioprotection of normal tissue cells

    Improvements of radiotherapy in combination with surgery and systemic therapy have resulted in increased survival rates of tumor patients. However,...

    Patrick Maier, Frederik Wenz, Carsten Herskind in Strahlentherapie und Onkologie
    Article 18 March 2014
  12. High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer

    Purpose

    Toll-like receptor 5 (TLR5) is a pattern recognition receptor and plays key roles in inflammatory responses against pathogen infection....

    Hui Zhou, Jian-hua Chen, ... Mei-zuo Zhong in Journal of Cancer Research and Clinical Oncology
    Article 19 February 2014
  13. Toll-like receptors in urothelial cells—targets for cancer immunotherapy

    Toll-like receptors (TLRs) have an important role in the activation of both innate and adaptive immunity in response to pathogens and danger signals....

    Hélène LaRue, Cherifa Ayari, ... Yves Fradet in Nature Reviews Urology
    Article 27 August 2013
  14. The Yin and Yang of Toll-like receptors in cancer

    Recognition of non-self molecular patterns by pattern recognition receptors is a cornerstone of innate immunity. Toll-like receptors (TLRs) exert a...

    J-P Pradere, D H Dapito, R F Schwabe in Oncogene
    Article 12 August 2013
Did you find what you were looking for? Share feedback.